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The recent massive increase in capability for sequencing genomes is producing enormous
advances in our understanding of biological systems. However, there is a bottleneck in genome
annotation – determining the structure of all transcribed genes. Experimental data from MS
studies can play a major role in confirming and correcting gene structure – proteogenomics.
However, there are some technical and practical challenges to overcome, since proteogenomics
requires pipelines comprising a complex set of interconnected modules as well as bespoke
routines, for example in protein inference and statistics. We are introducing a complete, open
source pipeline for proteogenomics, called ProteoAnnotator, which incorporates a graphical
user interface and implements the Proteomics Standards Initiative mzIdentML standard for
each analysis stage. All steps are included as standalone modules with the mzIdentML library,
allowing other groups to re-use the whole pipeline or constituent parts within other tools. We
have developed new modules for pre-processing and combining multiple search databases,
for performing peptide-level statistics on mzIdentML files, for scoring grouped protein identi-
fications matched to a given genomic locus to validate that updates to the official gene models
are statistically sound and for mapping end results back onto the genome. ProteoAnnotator
is available from http://www.proteoannotator.org/. All MS data have been deposited in the
ProteomeXchange with identifiers PXD001042 and PXD001390 (http://proteomecentral.
proteomexchange.org/dataset/PXD001042; http://proteomecentral.proteomexchange.org/
dataset/PXD001390).
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1 Introduction
Accurate gene annotation is a challenging stage in genome
sequencing pipelines. The rapidly lowering cost of next-
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generation sequencing makes it difficult for genome annota-
tion pipelines to keep pace. Gene annotation can be achieved
either manually or via automated pipelines. While manual
annotation of protein-coding genes is usually more reliable,
it may not always be feasible due to time constraints. There-
fore, genome annotations are mostly based on predictions,
where traditional gene annotations software pipelines use ex-
ternal evidence to enhance the accuracy of the genemodels of
any organism (reviewed in [1]). Gene-finding software often
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introduces errors in annotating the gene models of Eukary-
otic organisms, since the correct prediction of splice sites
and the position of the first exon do not have motifs that
can be easily predicted. Various experimental techniques are
used to provide supporting evidence for exon–intron struc-
ture, such as ESTs and mRNA transcript sequencing (RNA-
Seq), including evidence for alternative splicing of transcripts
[2]. Most genome projects now incorporate some transcript
sequencing to facilitate annotation. However, all RNA-based
methods for annotation have the drawback that they cannot
provide direct evidence that a putative splice product is trans-
lated into a genuine protein molecule in a given biological
system.
In the context of proteomic investigations, LC-MS can pro-
duce protein identifications and quantitative data on a large
scale. In a classic ‘shotgun’ pipeline, MS data are collected
from peptides resulting from proteolysis of the total protein
pool. Most commonly, modern instruments function in two
steps (MS/MS) where peptides are fragmented in the second
step (MS2) and each MS2 spectrum is queried by a search
engine (such as MASCOT [3], OMSSA [4], X!Tandem [5] or
MSGF+ [6]) against a protein sequence database to make a
peptide spectrum match (PSM). MS data can be used to an-
notate the genome of any organism, in theory providing evi-
dence for an isoform resulting frompredicted splicing, for the
correct start codon of a gene, as well as single amino acid poly-
morphisms and PTMs. However, proteogenomics is a chal-
lenging task – as genome annotations (‘official’ gene model
sets) change on a regular basis – often once per year, render-
ing proteomics identifications to previous releases out-of-date
and requiring a re-analysis with respect to the new models.
There are also technical and practical challenges, including
the requirement for a complex interconnected pipeline of
modules often not designed with proteogenomics in mind,
and often proving difficult to integrate due to file format or
design incompatibility.
Various groups have produced software for proteoge-
nomics. An early initiative in this direction was the genome
annotating proteomic pipeline [7], using the open source
X!Tandemsoftware to query against particular genomebuilds
from a relational database. A recent tool Peppy [8] performs
the most common proteogenomics tasks, such as generat-
ing a peptide database from a genome, tracking peptide loci,
matching peptides to MS/MS spectra and performing false
discovery rate (FDR) analysis. The PG Nexus [9] allows users
to visualise peptides in the context of genomes – done in the
Integrated Genome Viewer. PG Nexus is integrated into the
Galaxy cloud environment [10] and is available in the Galaxy
tool shed. Genomics and transcriptomics data sets can be
used as custom sequence database in MASCOT searches.
The Samifier tool [9] then converts the output results from
MS/MS searches into a .SAM file format that can be visu-
alised in the Integrative Genomics Viewer. The iPiG tool [11]
integrates peptide identifications from MS data into existing
genome browser visualisations. It also supports input (but
not output) of themzIdentML standard for the identified pep-
tides. However, the tool does not perform post-processing, it
relies on prior FDR estimation methods.
While database search algorithms are most commonly
used in this space, they are limited to identifying a pri-
ori predicted sequences present in the protein database.
Another approach is de novo sequencing that does not re-
quire a protein database, but there is a general consensus
that purely de novo approaches exhibit overall weaker perfor-
mance (lower sensitivity vs. specificity) than those based on
sequence database search. However, tools such as GenoMS
[12] use the combined strengths of database and de novo
methods. In GenoMS, the database search tool InsPecT [13]
is used to identify protein sequence templates. Then, these
templates are used to sequence de novo regions of the target
protein that are missing or diverged from the database.
Recent work by Castellana et al. [14] queried MS data
against a combined six frame translation and a splice graph
(formed from experimental mRNA sequences mapped to the
genome aswell as predicted splice sites), followed by genomic
clustering of PSMs to identify regions likely to contain genes
missed in the annotation. The study was able to identify a
large number of novel genes and updates to existing genes.
To our knowledge, there is no single pipeline that is au-
tomated (requiring almost no complex setup procedures or
parameterisation), incorporates bespoke algorithms for ge-
nomic loci identification and scoring and performs the com-
mon tasks for a proteogenomics pipeline using Proteomics
Standards Initiative (PSI) for each analysis step. Therefore,we
are introducing an open source pipeline for proteogenomics,
called ProteoAnnotator. ProteoAnnotator has a simple setup
procedure, a graphical interface for end users (such as labora-
tory scientists) or command linemode for informatics groups
wishing to run it in a parallel environment. ProteoAnnotator
is implemented using the PSI mzIdentML standard data for-
mat [15] for peptide and protein identifications, and an associ-
ated library of routines [16]. By using mzIdentML, individual
modules of ProteoAnnotator can be incorporated into other
tools and the outputs can also be directly submitted to the
ProteomeXchange central database [17] and PRIDE [18]. Pro-
teoAnnotator can be downloaded as a single, self-contained
zip archive from http://www.proteoannotator.org/.
2 Materials and methods
2.1 ProteoAnnotator structure and modules
ProteoAnnotator comprises a set of modules that can be used
as individual tools or as a combined pipeline for genome an-
notation. It can be run in two different modes: command line
mode and graphical user interface mode. ProteoAnnotator is
designed to be user-friendly from the installation phase to
running with a minimum effort. Moreover, ProteoAnnota-
tor is designed using a modular structure that allows bioin-
formatics groups to easily use, run and adapt the pipeline
to match their need. ProteoAnnotator is released under the
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Apache 2.0 licence so that other groups can use the code,
modules or the complete pipeline in other projects without
restriction.
The ProteoAnnotator pipeline (Fig. 1) takesGFF3 (genome
coordinates) and FASTA (protein sequence) file formats as
search database inputs. The FASTA file is optional if the
GFF file already contains the FASTA-formatted data within
the file (since this is optional in GFF3 format). The design
of ProteoAnnotator requires that the user uploads one set
of genomic coordinates and protein sequences as the cur-
rent ‘official’ models for the genome of interest – these are
flagged as the ‘A’ gene/protein set for further analysis steps.
In case the genome has recently been sequenced with no of-
ficial models, the user should upload the set of gene models
considered to be the most high quality, for example as pre-
dicted by gene-finding software. The user then has the option
to upload an unlimited number of additional sets of predicted
gene models in order of quality preference – flagged as ‘B’,
‘C’, ‘D’ set and so on. The pipeline then produces a single
concatenated FASTA file. ProteoAnnotator uses the MzidLib
routines [16] for pre- and post-processing and SearchGUI
[19] for creating a decoy databases and running the MS/MS
search using Omssa and X!Tandem (SearchGUI is an open
source tool that allows running a search using different open
source search engines). Figure 1 shows the ProteoAnnota-
tor workflow and modules used. While some modules are
already being published and used [16], a new set of mod-
ules were developed and added to the MzidLib specifically
for ProteoAnnotator and SearchGUI integration. Table 1 lists
ProteoAnnotator command line parameters. A detailed de-
scription of each step of the ProteoAnnotator pipeline is as
follows.
Step (a) Creating generic FASTA files: The FASTA format
used as input to database search engines does not have
a standardised header, therefore this stage gives a uni-
formly structured protein accession and description to en-
sure the search engines embedded in SearchGUI function
correctly.
Step (b) Search database concatenation: ProteoAnnotator in-
corporates multiple search databases generated by gene
finding software or derived by assembly from RNASeq
data, to be compared versus the official gene set. This
step concatenates multiple databases, adding a prefix to
the accessions from each input set in order of database
preference (A, B, C, D, and so on), which is picked up by
the protein-grouping algorithm downstream.
Step (c) Creating a decoy database: This step is performed
by SearchGUI [19] to create a concatenated target-decoy
database, containing reversed target sequences, used for
FDR calculation.
Step (d) Running the MS/MS search: The search is done
via SearchGUI. In ProteoAnnotator we use OMSSA and
X!Tandem, although SearchGUI also incorporatesMSGF+
and MS-Amanda (http://ms.imp.ac.at/?goto=msamanda)
that may be incorporated into later builds of ProteoAnno-
tator if testing demonstrates superior performance from
their inclusion.
Step (e) Format conversion of search outputs: The native file
formats of OMSSA (OMX) and X!Tandem (“extensible
markup language”) are converted to mzidentML, using
a module from MzidLib previously described [16].
Step (f) Combine mzIdentML files: If multiple MASCOT
generic format (MGF) files are provided as input as a
single analysis unit, the results can be combined prior
to protein grouping. This step removes redundant pro-
tein and peptide entries, concatenating the PSMs within
the file – keeping references to the source MGF file in-
tact internally. Each individual file is limited to <1 GB
size and <25 000 scans since SearchGUI automatically
splits files above this limit, and it becomes harder to trace
data through the ProteoAnnotator. In a future build, we
will add automated splitting of files if they are above the
limit.
Step (g) Combining search engines outputs: This module re-
scores and combines PSMs from two or three search en-
gine (OMSSA and X!Tandem only in the current build) to
produce a single output, using the algorithm previously
described [20].
Step (h) Determining the FDR at the peptide-level: Recent
debate in the literature suggests that performing FDR
analysis and thresholding at (say) 1%FDRonPSMcan lead
to a higher level of FDR for peptides (discussed in [21]).
This is because highly abundant (true positive) peptides are
often observed inmultiple spectra – due to the peptide elut-
ing off a column for a period of time and being fragmented
on many occasions. False-positive peptide identifications
are often random events observed only once. As an exam-
ple, in a set of 1000 peptide identifications with 1% PSM
FDR (1000 target PSMs, ten decoy PSMs), one might ob-
serve 300 different target peptides and ten decoy peptides –
leading to peptide-level FDR of 3.3%. We have added a new
routine to the MzidLib for performing peptide-level statis-
tics, taking the best scoring PSM per peptide (ignoring
different modification and charge states), and re-applying
the algorithms described in [20]. This typically produces
more conservative estimates of FDR (and fewer peptides)
to be passed on to the protein-grouping stage. Note, there
are different methods of grouping PSMs per peptide, for
example taking into account modification states and/or
charge states of a peptide as different entities, which may
be implemented in ProteoAnnotator in due course if we
find demand for these methods.
Step (i) Peptide-level thresholding: The MzidLib [16] contains a
routine that allows an attribute to be set for each PSM in
the mzIdentML file passThreshold = true or false, based on
a given PSM-level score. We have adapted the routine to
account for peptide-level thresholding, setting passThresh-
old = true for only the best scoring PSM per peptide that
passes the threshold (1% peptide-level FDRScore is rec-
ommended for use in ProteoAnnotator, but users can alter
this value).
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Figure 1. The ProteoAnnotator workflow, as implemented in the MzidLib (blue rectangles), with file inputs (green ovals), outputs (green
rectangles) and SearchGUI integration (red rectangle). Steps (a–r) are explained in the Section 2.
Step (j) Adding genome coordinates to the mzIdentML file: This
module maps the positions (start/end within the protein)
of putatively identified peptides back onto the genome co-
ordinate system (including mapping peptides across mul-
tiple exons, as necessary), as specified in the GFF file.
Step (k) Protein inference: The ProteoGrouper algorithm is
described in [16], but has been adapted with a new scoring
scheme forProteoAnnotator. ProteoGrouper takes as input
the set of peptides confidently identified, based on the
threshold applied in Step (i). Peptide-level, protein-level
and protein-group level scoring are calculated as follows:
Each peptide contributing to protein identification is given
a peptide score (pepscore) as follows:
pepscore = − 10 − (10 × log10(peptide-level FDRScore)).
The peptide level FDRScore is an approximation of the lo-
cal FDR associated with a given peptide-level identification
(adapted from [20]) in ProteoAnnotator carrying values from
>0 to <0.01 following thresholding at 1% FDR, for example.
The equation converts values such that a peptide with peptide-
level FDR score = 0.01 gives pepscore = 10, peptide-level FDR
score = 0.001 gives pep score = 20 and so on, giving rise to
human readable score for protein-level identifications in the
following step.
Each protein (accession) identified is given a score
as follows ‘ProteoGrouper:PDH score’ (with accession
MS:1002235 in the PSI-MS controlled vocabulary [CV] [22]):
PDH score =
n∑
i=1
pepscorei,
where n is the total number of peptides mapped to a given
protein accession, i is the label given to each peptide and
pepscorei is the pepscore for peptide i. The set of pepscores
includes all the peptides that can be mapped to a given pro-
tein, regardless of the number of other proteins to which they
can also be mapped.
ProteoGrouper assigns all protein identifications to
groups, based on set relationships of peptides (accounting
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Table 1. The ProteoAnnotator command line parameters
Parameter Optional/mandatory Explanation
-prefix Optional A prefix to be attached to the output file names
-inputGFF A Mandatory The canonical GFF file
-inputFasta A Optional if the canonical GFF
contains the FASTA
The protein database
-outputFolder Mandatory The output folder for the analysis
-spectrum files Mandatory The MGF files to be searched
-searchParameters Mandatory The search parameters file to be used for the search in a
text file, following the format required for SearchGUI
-inputPredicted Optional The non-canonical gene models, these are a set of
GFF/FASTA files. The GFF and FASTA are separated by
‘;’ and the pairs are separated by ‘##’
-peptideThreshValue Mandatory The threshold implemented for peptide-level FDR (0.01 is
the recommended value and default in the interface)
-proteinThreshValue Mandatory The threshold implemented for protein group level FDR
(0.01 is the recommended value and default in the
interface)
for isoleucine/leucine ambiguity) as described in [16]. Each
protein group is assigned a score ‘ProteoGrouper:PAG score’
(PSI-MS CV identifier is MS:1002236) as follows:
PAG score =
nr∑
r=1
pepscorer +
nu∑
u=1
pepscoreu,
where nr and nu are the total number of razor and unique pep-
tides, respectively, mapped to the group leader of the protein
group.
The PAG score is based on summing the scores for pep-
tides classified as ‘unique’ within the group (can only be
mapped to a lead protein within the group) or ‘razor’ pep-
tides (the lead protein within the group has been assigned the
razor peptides as having more evidence for its identification
than any other protein in the list). The ‘ProteoGrouper:PAG
score’ can be used to determine the strength of evidence for a
given protein group to have been identified, relative to other
groups in the overall list. In ProteoAnnotator, a new score
is calculated by the module ‘ProteoAnnotator:non-canonical
gene model score’ (term identifier MS:1002474), which has
been added to the PSI-MS controlled vocabulary [22], so that
it is valid for use within mzIdentML. The non-canonical gene
model score is calculated as follows:
noncanonical gene model score =
nA∑
A=1
pepscoreA,
where nA is the total number peptides that do not map to ‘A’
(official) gene models within the protein group.
The score is calculated by summing the scores for indi-
vidual peptides that have been identified in a given protein
group, but which have not been identified in an official (A)
genemodel (in any protein group), and thus provide evidence
that the annotation can be improved for a given predicted
locus. All decoy peptide identifications (mapped into decoy
protein groups) are included in this score calculation (since
by definition they are notmapped to the official genemodels).
When the protein group list is ordered by the non-canonical
gene model score (Step p), the decoy protein groups give
a conservative background distribution against which any
loci determined to have evidence for improvements in the
genome annotation to be compared.
The ProteoAnnotator pipeline splits down to two pathways
(‘l, m, n’ and ‘o, p, q, r’) to provide users with two different
types of output. The former provides evidence that given pro-
teins and peptides originating from the official gene model
and/or alternative models have been identified. The latter
provides evidence that the official genome annotation has the
potential to be improved for loci confidently identified.
Step (l) FDR calculation for protein groups: The MzidLib: FDR
module is applied to order protein group identifications,
using the PAG score to order the list of target and decoy
identifications.
Step (m) Threshold for protein groups: A threshold is applied
at the protein group level, setting passThreshold = ‘true’
on those protein groups with q-value less than 0.01 (e.g.
1% protein group level FDR is recommended for use in
ProteoAnnotator, but users can alter this value).
Step (n) File format exports: This step exports results to var-
ious file formats, including a fully annotated mzIdentML
file (suitable for submission to a public repository such
as PRIDE/ProteomeXchange), a GFF3 file annotated with
peptide coordinates for visualisation in a genome browser
and various comma-separated values (CSV) file formats.
The following CSV exported files are produced: (i) a file
containing one row of data (including the details for the
representative protein) per protein group – suffix ‘ex-
portRepProteinPerPAGOnly.csv’, (ii) a file containing one
row per PSM identified – suffix ‘exportPSMs.csv’, (iii) a
file containing one row per protein accession that has been
assigned to any group in the protein list – suffix ‘export-
ProteinsOnly.csv’, (iv) a file containing one row per PSM
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supporting each protein accession in the protein list, along
with protein-level scoring and protein group assignment
(including redundancy in PSM to protein mapping) – suf-
fix ‘exportProteinGroups.csv’. The number of rows (pro-
tein groups) in file (i) with passThreshold = true gives
an indication of the overall number of loci that have been
identified – regardless of the number of search databases
included inStep (b). Eachprotein group is assigned a group
leader (by ProteoGrouper), based on the protein within the
grouphavingmost evidence, followedby alphabetical order
in the case of ties. This means that if an ‘A’ (official) gene
model-derived protein is identified with the same evidence
set (peptides) as a ‘B’ or ‘C’ non-official genemodel, the ‘A’
protein will be assigned as the group leader. Following this
strategy, any protein group in which an ‘A’ protein is not
the group leader indicates that at the given locus peptides
have been identified (so called alternative peptides) that do
not match the official gene models, and thus are candidate
regions for improving the genome annotation. However,
there is no statistical basis for assuming that such identi-
fications are significant at the genomic locus level – since
a single border-line peptide identification (say FDRScore
close to 0.01), that is not matched to the ‘A’ models, could
convey group leader status to a ‘B’ or ‘C’ model. Such pep-
tides can be randomly generated false-positives, especially
given that non-‘A’ databases could be large (e.g. generated
from six frame translations). As such, this view of the data
only gives an indication that a given locus may have evi-
dence for improvements to the given official gene model.
The statistical significance of matches to non-official gene
models is handled by workflow path (Steps o–r) as follows.
Step (o) Remove protein groups with no support for alternative
gene models: In this workflow path, the threshold module
is applied to remove any protein groups that have a non-
canonical gene model score equal to zero, that is the group
contains no evidence supporting an alternative annotation
at the given loci (all unique and razor peptides have been
assigned to an ‘A’ gene model). This is implemented by
deleting all protein groups from the result set that have
non-canonical gene model score < 0.00001.
Step (p) FDR analysis based on the non-canonical gene model
score: The FDR module is performed at the protein group
level using the non-canonical gene model score for ordering
all identifications (targets and decoys), calculating an esti-
mate of global FDR and a q-value for each protein group.
Step (q)Apply threshold based on non-canonical genemodel score:
The threshold routine is applied to protein groups, set-
ting passThreshold = true for protein groups with q-value
<0.05. This threshold value cannot be altered currently in
the graphical interface as we do not want to clutter the in-
terfacewith toomany parameters.No identifications are re-
moved at this step, the only difference being which protein
groups are flagged as passThreshold = ‘true|false’ in the
downstream mzIdentML and CSV files. In the CSV view,
users can easily perform different types of thresholding
for their own purposes, simply by ordering results by non-
canonical gene model score. The purpose of this step is
to determine the statistical significance of loci determined
to be carrying evidence for improvements to the genome
annotation, which we call alternative loci. This step ensures
a conservative calculation of q values, since the target loci
themselves may be well supported (a high PAG score) but
only the target peptides that do not match ‘A’ models con-
tribute to the non-canonical gene model score, whereas all
decoy peptides contribute to the score for decoy protein
groups. The distribution thus gives a background of the
rate of matches expected by chance to genomic loci in the
large concatenated databases. We apply a q-value threshold
of <0.05 rather than 0.01, since we know that the decoy
distribution is conservative, and due to the granularity of
the calculation. A typical data set may only have tens of loci
carrying a non-canonical gene model score and thus the first
decoy encountered in the ordered list would push the q-
value estimate over the 0.01 threshold. Genomic loci with
q values from 0.01 to 0.05 in this analysis should be treated
with care, as the level of evidence for an update to the
gene model annotation is clearly weak – usually based on
a single peptide identifications without a strong score.
Step (r) File format exports: The results of this pathway are
exported to mzIdentML and CSV files – which should be
used by genome annotators to prioritise those loci where
updates to the official genome annotation are most well
supported by proteomic data. The CSV file (suffix ‘export-
ProteoAnnotator.csv’) contains one row per protein group
identified, all of which carry some evidence for updates to
the annotation at a particular loci. The ‘A’ gene model(s)
present within each protein group are given in one cell
(allowing annotators to most easily locate the genes with
suggested improvements), along with the alternative pep-
tides identified and the non-canonical gene model score for
each group.
2.2 Validation and testing of ProteoAnnotator
The value of a proteogenomics pipeline for improving a
genome annotation is determined by the availability of large
MS data sets, mining deep into the proteome and the quality
of existing ‘official’ gene models – as the quality improves,
self-evidently the capability of improving the annotation de-
creases. Validating a proteogenomics pipeline is challenging,
since it is difficult to find a data set in which there is a known
‘ground truth’ to test against, in this case ‘ground truth’ are
the annotation improvements suggested by ProteoAnnotator
– which are real proteins – missed or incorrectly annotated in
the official gene set. As such, to validate the performance of
the ProteoAnnotator, we have performed a historic analysis
against two releases of official gene models for the Apicom-
plexan parasite Toxoplasma gondii, separated by several years
in which manual curation and the incorporation of RNASeq
transcriptome sequence data ‘improved’ the gene model
set, in a process independent from our proteogenomics
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Table 2. Case studies and data sets used to test the performance
of ProteoAnnotator
Case study Canonical gene
models
Non-canonical gene
models
1 TgondiiME49–6.0
(A model)
AUGUSTUS-6.0 (B model)
Glimmer-6.0 (C model)
2 TgondiiME49–10
(A model)
AUGUSTUS-6.0 (B model)
Glimmer-6.0 (C model)
analysis presented here. In this analysis, we downloaded the
official gene sets from ToxoDB [23] for the T. gondii release
6 (2009) and release 10 (2014). We also downloaded the
source genomic sequence T. gondii release 6 – which was
used to predict alternate candidate identifications using two
freely available gene-finding software packages – Augustus
[24] and GlimmerHMM [25]. We used Augustus to predict
a gene model set based on the T. gondii release 6 genome
sequence using the following parameters – genome file:
http://toxodb.org/common/downloads/release-6.0/Tgondii/
TgondiiME49Genomic ToxoDB-6.0.fasta; user set UTR
prediction: false; report genes on: both strands; alternative
transcripts: few; allowed gene structure: predict any number
of (possibly partial) genes; ignore conflicts with other strand:
false. Note that we experimented with several parameters,
including ‘Ignore conflicts with other strand: true’ and
‘Alternative transcripts: medium|many’, which made little
differences to the overall results (data not shown). For
GlimmerHMM, we used the default parameters and the
same input genomic DNA. We then performed two analyses,
as shown in Table 2. The purpose of the analysis was to
ask several questions. First, given that we know that T.
gondii gene model annotations in release 6 were imperfect
(many updates have since been made to the gene models)
– does ProteoAnnotator predict a set of loci for which gene
models can be improved (Case study 1)? Second, under the
assumption that the release 10 gene set is now considered
very high quality, the majority of the alternative peptides
identified in Case study 1 should be mapped to official gene
models in release 10 (Case study 2). If ProteoAnnotator is
producing a large number of random and incorrect loci
supported by alternative peptides, we should see a large
number of non-canonical loci identified in both pipelines.
Lastly, does ProteoAnnotator suggest that improvements can
still be made to the release 10 data set (Case study 2)?
Toxoplasma gondii RH tachyzoites were separated by 1D
SDS-PAGE on a 12% (v/v) acrylamide gel, from which 16
gel bands were excised and digested with trypsin. The di-
gests were then pooled into eight samples for LC-MS/MS
analysis. Peptide mixtures were analysed by online nano-
flow LC using the nano-ACQUITY-nLC system (Waters MS
Technologies, Manchester, UK) coupled to an LTQ-Orbitrap
Velos (ThermoFisher Scientific, Bremen, Germany) mass
spectrometer equipped with the manufacturer’s nano-spray
ion source.
The following parameters were set in ProteoAnnotator and
passed to SearchGUI: precursor tolerance 5 ppm, fragment
tolerance: 0.5 Da, fixed mods: carbamidomethylation on cys-
teine and variable modification of oxidation of methionine.
Other parameters were left as defaults, as described at the
SearchGUI website (https://code.google.com/p/searchgui/).
A further use of ProteoAnnotator (Case study 3) is to
demonstrate mapping or automated re-analysis of a data set
against a new or updated genome – including support for very
large input data sets. To demonstrate this functionality, we
have performed a re-analysis of a data set publicly accessible
from ProteomeXchange central (identifier PXD000652) from
a study on cerebrospinal fluid [26]. The original study looked
at seven different sample groups, we have analysed a single
sample group ‘CSF, gel separated, depleted fraction’ – consist-
ing of 46 different LC-MS runs derived from 1D SDS-PAGE.
The study used SearchGUI (as in ProteoAnnotator), but was
searched against UniProt. We wished to demonstrate that
ProteoAnnotator can be used to map to the relevant canoni-
cal genome sequence – in this case we searched against the
current Ensembl Human build 76 [27], otherwise following
the same search parameters as reported in [26].
2.3 ProteoAnnotator interface
ProteoAnnotator can be run within Proteosuite, which
is a tool originally designed for quantitative proteomics,
and now incorporating ProteoAnnotator (http://www.
proteosuite.org/). The pipeline can be run in the GUI as
follows: (i) raw MGF data are loaded into Proteosuite, and
the genome annotation option is checked.MultipleMGF files
may be selected, which will be combined following the search
step and prior to CombineSearchEngines (Step (f); Fig. 1). (ii)
Search parameters and ProteoAnnotator options are set via
a form as shown in Fig. 2. Many of these options are di-
rectly passed on to SearchGUI. Users are expected to enter
one official gene set, and optionally add several non-official
gene sets, as GFF3 formatted files. GFF3 data for each gene
model set are mandatory, however, a separate FASTA file
containing protein sequences is only mandatory if the GFF3
file lacks protein sequences. Protein sequence data should
contain only targets, no decoys – the pipeline takes care of
decoy database generation. (iii) The pipeline is started using
the ‘Run’ button, and the user is later notified when it is com-
pleted. The output of the pipeline may be inspected in the
‘annotation output’ folder where the raw data were located.
Output items of interest include newly annotated GFF3 file
(for each gene model set entered), various mzIdentML files,
various CSV files (as described above) and a log file called
ProteoAnnotator.txt.
3 Results and discussion
The summary results for the two T. gondii case studies are
presented in Table 3 and in Supporting Information Files
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Figure 2. The ProteoAnnotator graphical user interface, as implemented in Proteosuite.
1–6. The results give confidence that ProteoAnnotator is
functioning to produce coherent and statistically sound
results. Overall, broadly the same number of protein groups
and peptides are confidently identified in both case studies,
indicating that the overall set and number of loci that can
be identified has not radically altered between T. gondii re-
lease 6 (1619 protein groups) and release 10 (1611 protein
groups) gene models. For comparison, when ProteoAnno-
tator is run solely with this data set against only the re-
lease 10 official models, 1571 protein groups are identified at
q < 0.01 (data not shown). Indicating that even though the
search database is several fold larger in the re-annotation case
studies, there is no large increase in the overall number of
proteins identified, which would suggest false-positive iden-
tifications are being made.
In comparing the results from Case study 1 and 2, we see
a large difference in the number of alternative loci and alter-
native peptides. In Case study 1, we see 83 alternative loci
passing the threshold, supported by 289 alternative peptides.
In Case study 2, the number of alternative loci has dropped to
15, supported by only 35 alternative peptides. These results
suggest that for the proteins identifiable from this data set
(approximately 1600) in 2009, around 5% of the loci could be
improved by the pipeline, falling to less than 1% in the 2014
release. We cannot determine that these 1600 gene mod-
els in release 10 are now all broadly correct, since these are
Table 3. Summary of results from the two case studies described in the methods
Total protein groups
identified at q-value
(0.01)
Total peptides
identified at q-value
< 0.01
Total alternative loci
identified at q-value
< 0.05
Total alternative
peptides within the
alternative loci
passing threshold
Case study 1 1619S1 10261S2 83S3 289S3
Case study 2 1611S4 10299S5 15S6 35S6
The superscripts relate to the Supporting Information Files (1–6) in which the evidence for each count is presented.
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Figure 3. A visualisation of the top scoring alternative loci (Augustus prediction g5397.t1) in the ToxoDB genome browser. The data have
been aligned with: (A) RNASeq-generated splice junctions mapped onto release 10 official genes; (B) the corresponding official gene in
release 10; (C) the peptide mapped to this gene in Case study 2; (D) the Augustus predicted gene models; (E) the peptides mapping onto
Augustus models from Case study 1; (F) the peptides mapping onto the official gene models in release 6 and (G) the official gene models
in release 6. Lastly, the 5′ exons that appear to have been missed in release 6 and added in release 10 are boxed (H).
heavily influenced by the overall peptide sequence coverage
that is likely to be low formany of these proteins – our analysis
presented here is based on a single LC-MS run. However,
for the purposes of benchmarking, this demonstrates that
ProteoAnnotator is not producing a large number of ran-
dommatches to non-canonical gene sets. A large-scale meta-
analysis of numerous shotgun data sets for T. gondii is in
progress using ProteoAnnotator, and will be submitted for
publication shortly.
As a representative example, we examined the highest scor-
ing alternative loci in Case study 1 to demonstrate the effec-
tiveness of the pipeline. The top hit was to Augustus predic-
tion g5397.t1 that was grouped with release 6 gene model
TGME49_111470 (Supporting Information File 3). The pro-
tein group had a non-canonical gene model score = 476,
supported by 20 ‘non-A’ peptides. A search of ToxoDB for
TGME49 111470 (release 6 accession) maps this protein to
TGME49 311470 (release 10 accession), with functional an-
notation of ‘rhoptry neck protein RON5’. We have uploaded
the ProteoAnnotator-produced GFF3 files into ToxoDB, en-
abling this region to be visualised, as shown in Fig. 3.
To produce Fig. 3, a bespoke script was used to re-align
the coordinate sets for loci and peptides mapped to release
6 – since the genomic coordinates themselves have altered by
a small amount on each chromosome between releases 6 and
10. The results demonstrate that a large number of 5′ exons
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had been missed in the release 6 gene prediction (Fig. 3H).
These exons were predicted by Augustus and 20 peptides
were mapped onto these exons. These exons have now been
added to the annotation in release 10, and are supported by
high-quality RNASeq data sets. However, it is also interesting
to note that the six most 5′ exons appear to have no support
in the RNASeq data or from peptides in this study, indicating
that perhaps further annotation may yet be required. This ex-
ample gives a graphical demonstration of the capabilities of
ProteoAnnotator for supporting gene model improvements
– which, via our historical analysis, we can demonstrate have
been independently verified.
In Case study 2, only 15 alternative loci are identified with
q-value < 0.05. Many of these are supported by a single-
peptide identification – which perhaps may indicate single
exons that have been missed in the current annotation, and
for those with q values approximately 0.01–0.05 should be
treated with caution, since they could be false-positive iden-
tifications. However, there are several alternative loci with
strong support from a number of alternative peptides, for
example Augustus prediction g6646.t1 has a non-canonical
genemodel score= 392, supported by 12 alternative peptides.
Preliminary analysis suggests that this is a predicted tran-
script from a region of DNA that has not yet been assembled
onto a chromosome, and thus missed in the release 10 anno-
tations. This simple example demonstrates that even though
the T. gondii release 10 gene models are now of high qual-
ity, there are still improvements to be made from proteomic
data. The data for Case study 1 and 2 have been submitted to
ProteomeXchange central under identifiers PXD001042 and
DOI 10.6019/PXD001042.
The purpose of Case study 3 was to demonstrate the ca-
pability for using ProteoAnnotator with a large input data
set, and for mapping against the human genome of consid-
erably higher complexity than the apicomplexan genomes.
In the initial publication for data set PXD000652 [26], the
authors analysed the data in a search against UniProt – re-
sulting in 1623 protein group identifications (downloaded
from the CSF website: ‘gel depleted fraction results’). Our
analysis searched against the latest Ensembl build yielded
1703 protein groups (Supporting Information File 7). To de-
termine the cross-over in these two sets, we used the Uniprot
IDmapping service (http://www.uniprot.org/uploadlists/) to
retrieve Ensembl protein identifiers for all of the accessions
identified in the CSF study (1799 identifiers within the 1623
groups). The mapping service was able to map 1736 of 1799
accessions (96%) to Ensembl – the reason for the other iden-
tifiers not mapping is unknown (but a common problem
between different databases). We then performed an analysis
to determine how many of the CSF study protein groups had
also been identified by our ProteoAnnotator analysis, which
was 1531 of 1623 (94%) – see Supporting Information File
7. Given that there is a 4% loss in the identifier mapping
process, it appears that there is high agreement between the
identifications made in the original study and those made
by ProteoAnnotator (approximately >97% agreement). This
provides confidence that ProteoAnnotator is functioning cor-
rectly to map identifiers to Ensembl and, as demonstrated by
the challenges of even mapping identifiers across resources,
highlights the importance of having a pipeline that can query
mass spectra directly against a genome of interest. Case study
3 has also been uploaded to ProteomeXchange under acces-
sion PXD001390 and DOI: 10.6019/PXD001390.
4 Concluding remarks
We present version 1.0 of ProteoAnnotator pipeline, which
has been embedded in the MzidLib. We believe the pipeline
will assist in proteogenomics studies at various stages of ma-
turity. ProteoAnnotator can be deployed easily via a graphical
user interface in our Proteosuite software, or as a command
line tool for integration into other projects or for use on high-
performance compute clusters. Each module described can
be deployed in isolation, fostering re-use and integration into
other tool kits. ProteoAnnotator exports file formats for ge-
nomic integration (GFF3) and for submission to public pro-
teomics repositories (mzIdentML).
We are continuing to develop ProteoAnnotator – and in
the future will release versions capable of functioning on the
Galaxy cloud (working with the Bessant Bioinformatics Lab at
the Queen Mary University of London) and developing tools
for ‘blind’ modification identification. The design mode also
means that new routines, such as improved database design
strategies, new search engines, new statistical routines and
new visualisation or export formats, can be easily incorpo-
rated as new modules within the MzidLib project.
The MS proteomics data in this paper have been deposited
in the ProteomeXchange Consortium (http://proteomecentral.
proteomexchange.org) via the PRIDE partner repository [18]:
dataset identifiers PXD001042 and PXD001390. The authors
thank the Toxoplasma Genomic Resource (ToxoDB) for provid-
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in the ProteoAnnotator pipeline. The authors also thank the
PRIDE team for assistance in uploading data sets to the pub-
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